The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors https://www.biorxiv.org/content/10.1101/2023.05.24.542123v1?med=mas
The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors https://www.biorxiv.org/content/10.1101/2023.05.24.542123v1?med=mas